BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 16 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 17 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 18 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 16 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 17 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 18 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago
ADVERTISEMENT
Market News

Diebold (NYSE: DBD): Q3 2019 Earnings Snapshot

— Diebold Nixdorf (NYSE: DBD) reported a third-quarter 2019 adjusted loss of $0.06 per share versus a profit of $0.24 per share expected. — Total net sales declined by 4% to $1.08 billion versus $1.1 billion expected. The results were impacted by persistent currency headwinds and certain slow economic activity, notably in Europe, which is […]

$DBD October 29, 2019 1 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results
NYSE
$DBD · Earnings

— Diebold Nixdorf (NYSE: DBD) reported a third-quarter 2019 adjusted loss of $0.06 per share versus a profit of $0.24 per share expected. — Total net sales declined by 4% to $1.08 billion versus $1.1 billion expected. The results were impacted by persistent currency headwinds and certain slow economic activity, notably in Europe, which is […]

· October 29, 2019

— Diebold Nixdorf (NYSE: DBD) reported a third-quarter 2019 adjusted loss of $0.06 per share versus a profit of $0.24 per share expected.

— Total net sales declined by 4% to $1.08 billion versus $1.1 billion expected. The results were impacted by persistent currency headwinds and certain slow economic activity, notably in Europe, which is hurting customer demand for Retail solutions.

Earnings Update by AlphaStreet

— Sales from Eurasia Banking declined by 7% while that from the Americas Banking increased by 6%. Total retail sales fell by 11%.

— Looking ahead into the full year 2019, the company lowered its total revenue outlook to about $4.4 billion from the previous estimate of about $4.5 billion.

ADVERTISEMENT

— Adjusted EBITDA is now expected to be in the range of $400 million to $410 million compared to the prior forecast range of $400 million to $420 million.

— Net cash provided by operating activities is now predicted to be in the $120 million to $150 million range, up from the earlier forecast of about $100 million.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT